






































































Medical	imaging	has	enormous	potential for	early	disease	prediction,	but	is impeded by	the	difficulty	and	
expense	of	acquiring	datasets	prior	to	symptom	onset.	UK	Biobank aims	to	address	this	problem	directly
by	 acquiring	 high	 quality,	 consistently	 acquired imaging	 data	 from	 100,000	 predominantly	 healthy	
participants,	with	health	outcomes	tracked	over	coming	decades.	The	brain	imaging	includes	structural,	
diffusion	and	 functional	modalities. Along	with	body	and	cardiac	 imaging,	genetics,	 lifestyle	measures,	
biological	phenotyping	and	health	records,	this	is	expected	to enable	discovery	of	imaging	markers	of	a	
broad	 range	 of	 diseases	 at	 their	 earliest	 stages,	 as	 well	 as	 provide	 unique	 insight	 into	 disease	
mechanisms.	We	describe	UK	Biobank	brain	 imaging,	and	present	results	derived	 from	 the	 first	 5,000	
participants’	data	release.	Although	that covers just	5%	of	 the	ultimate	 cohort,	 it	 already	 yields a	 rich	
range	of	associations	between	brain	imaging	and	other	measures	collected	by	UK	Biobank.	
The	primary	clinical	role	of	brain	imaging	to	date	has	been	in	diagnosis	and	monitoring of	disease	progression,	
rather	than	providing	predictive	markers	 for preventative	stratification	or	early	 therapeutic	 intervention. The	
predominant	 strategy	 for finding image-based	 markers	 of	 neurological	 and	 psychiatric	 disease has	 been	 to	
identify	patients	early	in	the	diagnostic	process	to	maximize	statistical	power	in	a	small	cohort	(tens	to	hundreds	
of	 subjects). A	 key	 factor	 motivating	 the	 use	 of	 small,	 clinically-defined	 cohorts is	 the	 expense,	 time	 and	
specialized	hardware	associated	with	imaging.	This	approach	has	been	effective	in	providing	markers	of	disease	
progression,	but	 identifying imaging	markers	of	early	disease	requires	measurements	at	 the	pre-symptomatic	
stage.	Image-based	measures	of	brain	structure	and	function	may	evolve	in	a	complex	way	throughout	aging	and	
progression	 of	 neuropathology.	 Therefore,	 markers	 with	 utility	 in	 monitoring	 disease	 progression	post-
diagnostically	 may	 not	 manifest	 pre-symptomatically,	 and	 conversely	 the	 most	 sensitive	 early	 predictors	 of	
disease	may	have	plateaued	by	the	time existing diagnoses	become	accurate.
Nevertheless, when	known	risk	 factors	have	enabled	 risk-stratified	 cohorts, imaging	 has	 been	 able	 to	 predict	
disease before	 symptom	 presentation.	 For	 example,	 magnetic	 resonance	 imaging	 (MRI)	 has	 demonstrated	






studies suggest	 that the	 primary	 obstacle	 to	 identifying	 early	 imaging	 markers	 is	 in	 obtaining	 data	 in	pre-
symptomatic	cohorts	drawn	from	the	general	population.
Alternatively,	pre-symptomatic	cohorts	can	be	assembled	using	a	prospective	approach,	in	which	a	large	number
of	 healthy	 participants are	 intensively	 phenotyped	 (including	 imaging)	 and	 subsequently	monitored	 for	long-
2term	health	outcomes.	While	this	approach	is	expensive,	 it	 is	also	efficient	by	capturing	early	biomarkers	and	
risk	 factors	 for	 a	 broad	 range	 of	 diseases.	 It	 further	 becomes	 possible	 to	 discover	 unexpected	 interactions	
between	risk	factors	(such	as	 lifestyle	and	genetics). To	date,	 the	 largest	brain	 imaging	studies	have	gathered	
data	on	a	few	thousand	subjects.	While	 this	approach	has	 identified	associations	between	imaging	and	highly	
prevalent	 diseases,	 existing cohorts	 are	 still	 too	 small	 to	 produce	 sufficient	 incidence	 of	 many	 diseases	 if
participants	are	recruited	without	identifying	risk	factors.
UK	Biobank	is	a	prospective	epidemiological	resource	gathering	extensive	questionnaires,	physical	and	cognitive	




phenotypic	measures	 to	 long-term	 health	 outcomes.	 This	 is	 particularly	 powerful	 due	 to	 the	 combination	 of	
number	of	subjects	and	breadth	of	linked	data.	Participants	were	40-69	years	of	age	at	baseline	recruitment; this	











We present	example	analytic	approaches and	studies that	will	be	enabled	by	UK	Biobank. Identification	of	novel	

















three	 dedicated,	 identical centers	 operating	 7	 days/week,	 each scanning	 18	 subjects/day
7
.	 This	 places	 tight	
timing	 constraints,	 corresponding	 to	 one	 subject	 imaged	 every	 36	 minutes	 (see	 Online	 Methods).	 The	 first	
imaging	center was	built	to	establish	feasibility	and scanned	10,000	subjects	over	a	two-year	ramp-up	period.
Two	 further	 identical	 centers	 are	 being	 commissioned,	 with	 the	 three centers	 strategically	 positioned	 at
population	hubs: Manchester,	Reading	and	Newcastle.
The	 goal	 of	 capturing	 imaging	 phenotypes	 relevant	 to	 the	widest	 possible	 range	 of	 diseases	 and	 hypotheses	
meant	that	the	protocol	must	deliver	data	with	 the	broadest	predictive	power	 for	neuropathology	and	mental	
health.	We	 therefore	 included	modalities	that	drive	estimates	of	anatomical	and	neuropathological	 structure	(
“structural	MRI”),	brain	activity	 (“functional	MRI”,	 or	 fMRI),	 and	 local	 tissue	microstructure	 (“diffusion	MRI”,	
dMRI).	 The	 resulting	 imaging	 protocol	 (Supplementary Table	 1)	 included: three	 structural	 modalities,	T1-
weighted,	T2-weighted	and	susceptibility-weighted	MRI	(referred	to	here	as	T1,	T2	and	swMRI); dMRI;	and	both	
task	 and	 resting-state	 functional	 MRI	 (tfMRI	 and	 rfMRI).	 Recent	 advances in	 MRI	 acquisition	 technology
8
enabled	high	spatial	resolution	dMRI	and	fMRI	with	high	angular	and	temporal	resolution,	respectively,	despite	







image	processing	 to	 remove	 artefacts	 and	 align	 images	 across	modalities	and	 individuals,	most	 useful	 image	
3phenotypes	are	derived	through	complex	calculations	combining	many	voxels	and/or	images.	A	fully	automated	
processing	 pipeline was	 developed,	 producing	 both	 processed	 images	 as	 well	 as	 image-derived	 phenotypes	
(IDPs)	–	currently	2501	distinct	individual	measures	of	brain	structure	and	function.	Example	IDPs	include:	the	
volume	of	specific	brain	structures;	the	strength	of	connectivity	between	pairs	of	brain	 regions;	 the	estimated	






the	 following	 percentages	 of	 subjects:	 T2=97%,	 swMRI=93%, dMRI=95%, tfMRI=92%,	 	 rfMRI=95%.	 	 All
modalities	were acquired	and	usable in	89% of	subjects.	Results	from this	data	release	are	illustrated	in	Figs	1-4,
including	a	multimodal	atlas	(separate	population-average	images	for	each	of	the	modalities,	all	aligned	to	each	





The	 three	 structural modalities	 (Fig	 1)	 provide	 information	 about	 different	 aspects	 of	 the	 brain’s	 tissues,	


















	 (e.g.,	 small	 vessel	 ischaemic	 disease),	 as	 well	 as	 occurring	 with	 increasing	











Diffusion	MRI	 (Fig	2)	 reflects	 the	 random	diffusion	 of	water	molecules,	which	 is	 affected	by	 the	microscopic	
structure	 of	 tissue
14
,	 enabling	 us	 to	 infer	 the	 local	 density	 of	 cellular	 compartments	 in	 tissue	 (e.g.	 neurites).	
Additionally,	 axon	 bundles	 in	 white	 matter	 create	 an	 orientation	 dependence	 of	 water	 movement	 due	 to	
hindrance	of	diffusion	perpendicular	to	the	long	axis	of	white	matter	tracts,	an	effect	that	can	be	tracked	from	
voxel	 to	 voxel	 (“tractography”)	 to	 derive	 long-range	white	matter	 pathways.	 Three	 complementary	 diffusion	
models	 were	 fit	 to	 the	 signal	 in	 each	 voxel:	 (i)	 the	 diffusion	 tensor	 model
15
,	 describing	 the	 signal	
phenomenologically	as	resulting	from	a	3D	ellipsoid	profile	of	water	displacement;	 (ii)	 the	neurite	orientation
dispersion	 and	 density	 imaging	 (NODDI)	 model
16




within	a	voxel for	tractography.	675	IDPs	were	extracted,	by	averaging	parameters	estimated	by	 the	 first	 two	







changes	 in	 neural	 metabolic	 demand
20
.	 The	 task	 deployed	 in	 tfMRI	 (Fig	 3)	 involves	 matching	 shapes	 and	
emotionally	negative	faces
21
	and	was	chosen	to	engage	a	 range	of	neural	 systems,	 from	 low-level	 sensory	and	
motor	 to	 perceptual	 (e.g.,	 fusiform)	 and	 emotional	 (e.g.,	 amygdala)	 areas.	 The	 16	 tfMRI	 IDPs	 quantitate	 the	
strength	of	brain	activity	changes	for	specific	aspects	of	the	task,	 in	regions	defined	using	the	group-averaged	
activation	maps	shown,	 in	three	task	conditions.	Resting-state	fMRI	(Fig	4)	 identifies	connected	brain	 regions	
4based	on	common	 fluctuations	 in	activity	over	 time	 in	 the	absence	of	 an	 explicit	 task
22





















FA-based	 IDPs	 exhibit	 this	 significant	 positive	 correlation,	 demonstrating	 that	 averaging	 across	 tracts	 can	
sacrifice	 richness	 of	 information.	 The tensor	 mode
24









A	 further	 example	 voxelwise	 analysis	 is	 shown	 in	 Supplementary	 Fig	 1,	 where	 the	 rfMRI	 data	was	 used	 to	
investigate	aging	effects	in	 the	default-mode	resting-state	 network
25
.	 This	also	 provides	 a	demonstration	 that	
group	 analyses	 do	not	 degrade	with	 increasingly-large	 subject	 numbers	 (e.g.,	 due	 to	 alignment	 issues),	 using
group	sizes	from	15	to	5000.	With	increasing	subject	numbers,	background	noise	is	suppressed	without	increase	






(Figs 1-4,6,	Supplementary	Fig	2). Even	after	 false	discovery	rate	 (FDR)	multiple	 comparison	correction	for	
these	 2.8	 million	 correlations,	 57	 out	 of	 the	 66	 combinations	 of	 brain	 modalities	 and	 non-brain-imaging	
categories show	significant	associations.	Some	variable	categories exhibited	large	numbers	of	associations	with	
IDPs	(e.g., height	and	weight),	whereas	others	(e.g. cognitive	measures	and	alcohol/tobacco	 intake)	had	more	
focused associations.
The	above	associations	were	estimated	after	adjusting	all	variables	for	age,	sex,	age-sex	interaction,	head	motion	




the	 appropriateness	 of	 de-confounding	 depends	 on	 the	 question	 being	 asked	 and	 needs	 to	 be	 taken	 into	
consideration	 when	 interpreting	 associations	 (see	 Discussion). The	 relationship	 between	 the	 correlations	
estimated	 with	 vs. without	 de-confounding	 (Fig	 6d) demonstrates	 that	 in	 almost	 all	 cases	 the	 strength	 of	
association	was	 reduced	 by	 de-confounding, in	 some	 cases being	 almost	 entirely	 removed	 (horizontal	 cloud	
around	y=0).





with	and	without adjusting	for	age. The	task-fMRI	vs.	Fluid	Intelligence	associations are	unchanged	by	adjusting	
for	 age,	whereas	 all	 other	 cognition-IDP	 correlations	 are	 approximately	 doubled, being significantly stronger
5(Pcorrected<0.005) without	age	adjustment.
In	the	Symbol	Digit	Substitution	test,	participants	replace	symbols	with	numbers	using	a	substitution	key. Strong	






as	discussed	above	may	reflect	variations	 in	 tract	 thickness
28
).	 Finally,	 there	was	 significant	 association	with	
thalamus	 volume	 (right	 thalamic	 volume	 significant,	 left	 thalamic	 volume	 close	 to	 significance	 with	 r=0.10),	
consistent	with	 literature
29




similar	 correlation,	 r=-0.06,	 but	 was	 below	 significance).	 These	 negative	 associations	 are	 consistent	 with
literature
30
	 and	 indicate	 increased	 volume	 correlating	 positively	 with	 cognitive	 speed	 (and	 negatively	 with	
reaction	time).
The	Fluid	 Intelligence	score	reports	how	many	numerical,	 logic	and	syntactic	questions	subjects	were	 able	 to
answer	 in	 two	minutes. This	was	 negatively	 correlated	with	 strength	 of	 gray	matter	 activation	 in	 the	 simple	
shapes	matching	task	in	tfMRI,	with	no	age	interaction. The	shapes	matching	task	incurs	low	cognitive	demand,	








with	 the	 same	 brain	 IDPs	 suggests	 that	 there	 is	 not	 a	 single	 (speed-related)	 cognitive	 factor	 at	 play.	 The	
increases	 in association	strengths	when	not	controlling	 for	age	suggest	 that	 age-related	 cognitive	 decline	 is	 a	
major	 source	 of	 cross-subject	 variability	 for	 these	 IDP-cognition	 associations
28
.	 Plotting all IDP-cognitive	
associations	 (Fig	6c)	 demonstrated	 that a	 large	 number	 of	 non-age-adjusted	 associations	 (gray	 circles)	were	
stronger	 than	 the	 results	 after	 age	 adjustment	 (colored	 circles);	 below,	we	 show	 how	 interpretation of	 such	
results	can	be	aided	 further	 through	multivariate	analyses.	These	age interactions	provide	an	early	 indication	
that	UK	Biobank should	provide cognitive	biomarkers	of	clinical	significance	as	health outcomes	accumulate.
Multivariate	associations:	modes	of	population	variation





) (see	Figs	7-8, Supplementary	Figs	3-7 and	Online	Methods).	This	analysis	identifies	











number	of	 subjects,	 the	 larger range	 of	 imaging	modalities	 and	 non-imaging	 variables,	 and	 the	 older	 subject	
ages.	
While	 these	 modes	 are	 not	 guaranteed	 to	 reflect	 biological	 processes,	 in	 practice	 ICA	 often	 produces	 such	
interpretability
35
.	 Of	 the	nine	modes,	 some	 reflected	 dominant	 physical	 factors	 (e.g., body	size	 or	 heart	 rate),
while	others	linked	rich	subsets	of	non-imaging	measures	to	IDPs. Modes	7-9	are	displayed	in	Fig	7,	with	modes	
7	and	9	discussed	 in	detail	below,	 continuing	our	 focus	on	 the	relationship	between	 IDPs	and	cognitive	 tests.




is	extensive	 literature	 linking	volume	 and	diffusivity	measures	 to	 cognition,	 but	 a	 relationship	 between	 these	
measures	and	bone	density	has	not	to	our	knowledge	been	reported.	This	link	could	reflect	variations	in	physical	












There	 is	 some	overlap	 between	modes	 7	 and	 9	 in	 terms	 of	 cognitive	 tasks	 (e.g., symbol	 digit	matches),	 bone	



















.	 We sought	 to	 replicate	 several	 of	 their	 key	 findings as	 a	 demonstration	 of	 a	 hypothesis-led	
investigation.	The	ASPS	study	reported R2*,	which	is	the	reciprocal	of	the	T2*	value	we	estimate	in	UK	Biobank;
therefore we	expected T2*	associations	with opposite	sign	 to	 those	 reported	by	ASPS. The	main	 results	 from	
ASPS	in	deep	gray	matter	structures	were	as	follows:	BMI	was	the	strongest	determinant	of	R2*	generally,	and	
was	significantly	related	to	R2*	in	amygdala	(beta=0.23, PFDR=0.009)	and	hippocampus	(beta=0.14, PFDR<0.0001).	
Further	 associations	 with	 R2*	 (averaged	 across	 subcortical	 structures)	 were	 found	 for	 age	 (beta=0.03,	 PFDR
=0.027)	 and	 recent	 smoking	 level	 (beta=0.02,	 PFDR=0.001).	 No	 equivalent	 associations	were	 found	 for	 sex	 or	
hypertension. The	ASPS	conducted	univariate	correlations	and	multiple	regressions	to	identify	both	shared	and	
unique	 variance	 in	 the	 associations,	 using	 FDR	 correction.	 Based	 on	 these	 results,	 we	 hypothesize	 negative	
association	between	T2*	in	subcortical	structures	with	BMI,	age	and	smoking.
We	conducted	similar	analyses,	applying	univariate	correlations	and	multiple	regressions	against	a	similar	set	of	
covariates	to	ASPS	 (see	Fig	8). The	regressions	used	 the	n=4,891	subjects	with	complete	data	 in	all	 IDPs	and	
covariates.	 In	 order	 to	 maximize	 the	 complementarity	 of	 information	 content	 between	 the univariate
correlations	 and	 multiple	 regressions,	 no	 adjustments	 for	 factors	 such	 as	 age	 and	 sex	 were	 applied	 in	
correlations,	whereas	 these	 factors	were	included	as	 confound covariates	 in	 the multivariate regressions. We	
applied	 Bonferroni multiple	 comparisons correction across	 covariates	 and	 brain	 regions,	 resulting	 (for	
Pcorrected<0.05)	in	a	-log10Puncorrected		threshold	of	3.6.
Our	results were	highly	concordant	with	ASPS.	BMI was	significantly	associated	with	T2*	in	amygdala	(averaged	












was	recorded	 from	the	 functional	data	 (not	 the	T2*	data),	 it	 is	 likely	 a	 general	 indicator	 of	 head	motion,	 and	
these	 results	 illustrate	why interpretation	 of imaging	 associations	 requires	 care.	 For	 example,	 BMI could	 be	
predictive	of	head	motion	(e.g.,	comfort	in	the	scanner)	while	also	potentially	relating	to	biophysical	parameters	
of	deeper	interest.
The	 BMI	 and	 smoking	 associations	 with	 T2*	 are	 found	 in	 distinct	 subcortical	 structures.	 Interestingly,	 this	
distinction	is	reflected	in	the	CCA-ICA	results,	where	 these	associations	appear	 in	separate	population	modes.
The	association	of	T2*	in	caudate	and	putamen	with	smoking	(and	more	weakly	with	alcohol,	Fig	8c)	is	highly	
7concordant	 with	 CCA-ICA	 mode	 5	 (Supplementary Fig	 4b),	 and	 is	 associated	 with aging	 (Fig	 8c	 and	
Supplementary Fig	8).	The	association	of	T2*	 in	hippocampus	 and	 amygdala	with	BMI	 is	 highly	 concordant	
with	CCA-ICA	mode	3	(Supplementary Fig	3c),	a	distinct	mode	of	population	covariation	that is	not	associated	




UK	Biobank	data	 is	 openly	 available	 to	 researchers	 including	 non-imaging	 experts.	However,	 imaging	 data	 is	
considerably	 more	 complex	 than	 most	 of	 the	 existing	 UK	 Biobank	 measures.	 Extensive	 post-processing	 is	
required	to	align	images	across	subjects	and	remove	artefacts.	Moreover,	information	is	usually	encoded	across	










A	 final	 challenge	 is	 that data	 sizes	 have	 become	 extremely	 large,	 requiring	 “big	 data”	 techniques;	 the	 brain	





even	 with	 multiple	 comparison	 correction.	 Large	 genome-wide	 association	
studies	(GWAS)	face	this	challenge,	where	it	 is	accepted	that	small	effect	sizes	can	be	meaningful,	particularly	
where	multiple	factors	combine	to	create	a	large	effect.	However,	in	GWAS,	genetic	variants	can	be	interpreted	
as	 causal	 factors	 (whether	 direct	 or	 indirect
42
),	 whereas	 apparent	 associations	 across	 IDPs	 and	 non-imaging	
phenotypes	could	result	from	a	shared	latent	(non-measured)	cause.	For	example,	education	level	could	result	in	












,	 in	 which	 suboptimal	 pooling	 across	 variables	 (here, sex)	 results	 in	 a	 misleading	











of	 focused	hypothesis	 testing,	 it	 is	 likely	 that	 carefully	 selected	 sub-groups	 of	 subjects	 should	 be	 utilized.	 For	
example,	once	a	group	of	subjects	 is	 identified	with	a	clinical	diagnosis,	 it	is	 likely	that	optimal	sensitivity	and	
interpretability	 will	 require	 a	 control	 sub-group	 that	 is	 matched	 over	 many	 relevant	 factors	 (e.g.	 sex,	 age,	
relevant	life	factors	not	appearing	in	the	predictive	model).
Future	studies	might	seek	to	find	causalities	between	variables,	for	example	using	structural	equation	modeling,	
Bayes	 Nets	 or	 non-linear/non-Gaussian	 methods
46







The	 mapping	 of	 disease	 associations	 and	 population	 patterns	 (e.g.,	 learned	 from	 UK	 Biobank	 data)	 onto	
individuals	will	be	an	important	long-term	goal.	For	example,	population	distributions	of	imaging	measures	and	
health	outcomes	can	be	learned,	and	used	to	form	patient-specific	prior	distributions	to	combine	with	measures	








several	 predictor	 variables. Nonlinear	 methods	 (e.g.	 penalized	 regression	 or	 data-driven	 feature selection)
22
could	 enable	 use	 of	much	 larger	 number	 of	 predictor	 variables.	 A	 further	 extension could	 identify	 nonlinear	
interactions	 between	 predictor	 variables,	 for	 example	 considering	 an	 imaging	 measure,	 a	 life	 factor	 and	 an	
interaction	 term	between	 the	 two	 as	 three	 distinct	 predictors.	 An	 even	more	 complex	 analysis	might	 predict









derived	measures. Data-driven	multivariate	 analyses	 identifying	 associations	 between	 sets	 of	 variables	 have	
complementary	benefits,	including improved	sensitivity	to	biological	processes	and a	streamlined	set	of	results
compared	with	millions	of	univariate	associations.	Further, multivariate	analyses	can separate distinct	biological	
processes	with	opposing	relationships	between	variables.	For	example,	our	CCA-ICA	analysis	revealed	one	aging-
related	process	 that	 involved	changes	 in	heart	 rate	and	 fMRI	measures	 (mode	4)	while	 another	 aging-related	
process	related	blood	pressure	and	white	matter	microstructure	(mode	8).	A	simple	correlational	analysis	would	
show	associations	between	all	of	these factors,	including	even	those	that	appeared	in	separate	modes	(e.g.	fMRI	
and	white	matter	 changes).	 Additionally,	 as	with	multiple	 regression,	 simultaneous	 identification	 of	multiple	
modes	of	association	reduces	the	unexplained	residual	variance	(effectively	data	“de-noising”).
Multivariate	 analyses	 of	multi-modal	 data	 like	 UK	 Biobank	 enable	 discovery	 of	 (potentially	 complex)	 clinical	
phenotypes.	This	is	a	powerful	alternative	to	diagnostic	categories	that	rely	on	clinical	symptoms	which	do	not	
map	 cleanly	 onto	 underlying	 disease	 mechanisms. For	 many	 complex	 diseases,	 the	 discovery	 of	 distinct	
mechanisms/sub-diseases	that	are	currently	conflated	may	be	unlikely	to	occur	solely	through	symptom-based	
investigations.	 Discovering	 relevant	 population	 axes	 and	 sub-groups	 based	 on	 imaging,	 genetics	 and	 other	
objective	markers	may	therefore	be	expected	to	increase	our	understanding	of	the	etiology	and	pathogenesis	of	a	





In	 the	 early	 2000s,	 several ambitious	 studies	 built	 cohorts	 numbering thousands	 of	 subjects.	 	 Several	 recent
brain	 imaging	 studies	 are	 aiming	 to	 image	 tens	 of	 thousands	 of	 subjects,	 including	 the	 Maastricht	 Study	
(n=10,000)
49
,	 the	 German	 National	 Cohort	 (n=30,000)
50
	 and	 the	 Rhineland	 Study	 (n=30,000).	 In	 addition	 to	
having	even	larger	numbers,	UK	Biobank will	benefit	from	the	breadth	of	organ	systems	imaged,	the	highly	multi-
modal	brain	protocol,	and	the	existing	rich	phenotyping. A	longitudinal	component	is	planned	for	a	subset	of	the
UK	Biobank imaging	participants (n=10,000),	as	 in	 the	Rhineland and	GNC	 studies.	Most	 of	 these	 studies	 use
identical	MRI	 scanners	 at	 a	 small	 number	 of	 dedicated	 sites,	 with	 the	 goal	 of	maximizing	 data	 homogeneity
within	study.	A	future	challenge	to	further	leveraging	these	large	datasets	is	to	develop	analysis	tools	that	can	




power	across	100,000	subjects,	but	 rather	 to	 provide	prospective	 imaging	 data	 suitable	 for	 discovering	 early	
markers	and	risk	factors	for	as	broad	a	set	of	diseases	as	possible.	For	some	rare	diseases	with	few	established	
risk	 factors,	 this	 approach	 is	 uniquely	 suited	 to	 discovery	 of	 pre-symptomatic	markers;	 for	 example,	 50-100
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Figure	 1	 	Data	 from	 the	 three	 structural	 imaging	modalities	 in	 UK	 Biobank	 brain	 imaging.	 (a)	 Single-subject	T1-
weighted	 structural	 image	with minimal	 pre-processing:	 removal	 of	 intensity	 inhomogeneity, lower	neck	 areas	 cropped	
and	 the	 face	 blanked	 to	 protect	 anonymity.	 Color	 overlays	 show	 automated	modeling	 of	 several	 subcortical	 structures	
(above)	and	segmentation	of	gray	matter	(below).	(b)	Single-subject	T2-weighted	FLAIR	image	with	the	same	minimal	pre-
processing,	showing hyperintense	lesions	in	the	white	matter	indicated	(arrows).	(c)	Group-average	(n≈4500)	T1	atlas;	all
subjects’	data	were aligned	together (see	Online	Methods	 for	processing	details)	and	 averaged,	 achieving higher	quality	
alignment,	with	clear	delineation	of	deep	grey	structures	and	good	agreement	of	major	sulcal	folding	patterns	despite	wide	
variation	in	these	features	across	subjects.	(d)	Group-average	T2	FLAIR	atlas.	 (e)	Group-average	atlas	derived	 from	SWI	
processing	of	swMRI	phase	 and	magnitude	 images.	 (f)	Group-average	T2*	 atlas,	also	derived	 from	 the	 swMRI	 data.	 (g)	
“Manhattan”	plot	 (a	 layout	common	 in	genetic	studies)	relating	all	25	 IDPs	 from	the	T1	data	 to	1100	non-brain-imaging	
variables	extracted	from	the	UK	Biobank	database,	with	 the	 latter	 arranged	 into	major	 variable	 groups	 along	 the	 x	 axis
(with	 these	 groups	 separated	 by	 vertical	 dotted	 lines).	 For	 each	 of	 these	 1100	 variables,	 the	 significance	 of	 the	cross-
subject	univariate	correlation	with	each	of	the	IDPs	is	plotted	vertically,	in	units	of	–log10(Puncorrected).	The	dotted	horizontal	













outputs,	 each	 sensitive	 to	 different	 aspects	 of	 the	 white	 matter	 microarchitecture.	 See	 Online	 Methods	 for	 processing	
details.	 The	 atlases	 shown	 are:	 FA	 (fractional	 anisotropy),	 MD	 (mean	 diffusivity)	 and	 MO	 (tensor	 mode);	 ICVF	(intra-
cellular	volume	fraction),	ISOVF	(isotropic	or	free	water	volume	fraction)	and	OD	(orientation	dispersion	index),	from	the	
NODDI	microstructural	modeling.	Also	shown	are	several	group-average	white	matter	masks	used	to	generate	 IDPs	(e.g.,	
pink	 (r)	 are	 retrolenticular	 tracts	 in	 the	 internal	 capsules;	 upper-green	 (s)	 are	 the	 superior	 longitudinal	 fasciculi).	 (b)	
Tensor	ellipsoids	depicting	the	group-averaged	tensor	fit	at	each	voxel	for	the	region	shown	inset	in	(c).	The	shapes	of	the	
ellipsoids	 indicate	 the	 strength	 of	 water	 diffusion	 along	 three	 principal	 directions;	 long	 thin	 tensors	 indicate	 single	
dominant	fiber	bundles,	whereas	more	spherical	tensors	(within	white	matter)	generally	imply	regions	of	crossing	fibers	
(seen	 more	 explicitly	 modeled	 in	 corresponding	 parts	 of	 (c)).	 (c)	 Group-averaged	 multiple	 fiber	 orientation	 atlases,	
showing	up	to	3	fiber	bundles	per	voxel.	Red	shows	the	strongest	fiber	direction,	green	the	second,	and	blue	the	third.	Each	
fiber	bundle	is	only	shown	where	the	modeling	estimates	that	population	to	have	greater	than	5%	voxel	occupancy.	Inset	
shows	 the	 thresholded mean	 FA	 image	 (copper)	 overlaid	 on	 the	 T1,	 with	 the	 region	 shown	 in	 detail	 in	 (b)	 and	 c)	
highlighted.	(d)	Four	example	group-average	white	matter	tract	atlases	estimated	by	probabilistic	tractography	 fed	 from	





the	 periods	 of	 the	 two	 task	 types	 (shapes	 and	 faces);	 for	 more	 information	 on	 this	 paradigm	 view,	 see	
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FEAT/UserGuide.	 (b)	Example	 fitted	 activation	 regression	model	 vs. timeseries	data	
(time	 running	 horizontally),	 for	 the	 voxel	most	 strongly	 responding	 to	 the	 “faces	 >	 shapes”	 contrast	 in	 a	 single	 subject	
(Z=12.3).	(c)	Percentage	of	subjects	passing	simple	voxel-wise	activation	thresholding	(Z>1.96)	for	the	same	contrast.	Note	
reliable	focal	activation	in	left	and	right	amygdala.	The	underlying	image	is	the	group-averaged	raw	fMRI	image.	(d)	Group-




details). Maximum	 r2	 =	 0.018,	minimum	 r2	 (passing	Bonferroni)	 =	0.0062. Dotted	horizontal	 lines	 (multiple	 comparison	
thresholds)	are	the	same	as	in	Fig	1g.
Figure	4			The	resting-state	fMRI	data	in	UK	Biobank.	 (a)	Example	group-average	resting-state	network	(RSN)	atlases	
from	 the	 low-dimensional	 group-average	 decomposition,	 showing	 four	 out	 of	 21	 estimated	 functional	 brain	 networks,
including	the	default	mode	network	(red-yellow),	dorsal	attention	network	(green),	primary	visual	(copper),	 and	higher	
level	visual	(dorsal	and	ventral	streams,	blue).	The	three	slices	shown	are	(top	to	bottom)	sagittal,	coronal	and	axial.	(b)	
The	55	non-artefact	 components	 from	a	higher-dimensional	 parcelation	 of	 the	 brain	 (axial	 views).	 These	 are	 shown	 as	
displayed	by	 the	 connectome	browser	 (www.fmrib.ox.ac.uk/analysis/techrep/ukb/netjs_d100),	which	 allows	 interactive	
investigation	of	individual	connections	in	the	group-averaged	functional	network	modeling.	The	55	brain	regions	(network	





















which	 show	correlations	with	all	 IDPs).	Whereas	 the	Manhattan	 plots	 in	Figs	 1-4	 indicated	 associations	 for	 each	 brain	
imaging	modality	separately,	here	we	depict	all	associations	in	a	single	plot.	(b)	List	of	all	IDP-cognitive	score	associations	
passing	Bonferroni	correction	 for	multiple	 comparisons	 (Pcorrected<0.05;	 Puncorrected<1.8x10
-8
).	 The	 first	 column	 lists	 the	age-
adjusted	 correlation	 coefficient,	 and	 the	 second	 shows	 the	 unadjusted	 correlation,	 both	 being	 correlations	 between	 a	
specific	brain	IDP	(fifth	column)	and	a	cognitive	test	score	(seventh	column).	UK	Biobank	cognitive	tests	carried	out	include	
Fluid	Intelligence,	Prospective	Memory,	Reaction	Time	(Shape	Pairs	Matching),	Memorised	Pairs	Matching,	Trail	Making	
(Symbol	Ordering),	 Symbol	Digit	 Substitution,	 and	Numeric	Memory.	 (c)	 IDP	 associations	with	 the	 cognitive	 phenotype	
variables	(the	full	set	of	174	cognitive	variables,	repeated	for	each	brain	imaging	modality).	Shown	behind,	in	gray,	are	the	







Figure	 7	 	 	 Details	 of	 three	modes	 from	 the	 doubly-multivariate	 CCA-ICA	 analyses	 across	 all	 IDPs	 and	non-brain-





links	 measures	 of	 bone	 density,	 brain	 structure/tissue	 volumes	 and	 cognitive	 tests.	Mode	 8	 links	 measures	 of	 blood	





strong	 functional	 network	 connections,	 we	 also	 show	 two	 functional	 nodes	 whose	 resting	 fluctuation	 amplitude	 is	
associated	with	this	mode.
Figure	 8	 	 	 Hypothesis-driven	 study	 of	 age,	 BMI	 and	 smoking	 associations	 with	 subcortical	 T2*. (a)	 UK	 Biobank
population-average	map	 of	 T2*,	 overlaid	with	 the	main	 subcortical	 structures	 being	 investigated.	 The	 T2*	 IDPs	 reflect	
individuals’	median	T2*	values	within	these	regions.	The	relatively	low	T2*	in	putamen	and	pallidum	likely	reflects	greater	
iron	content.	(b)	BMI	regression	betas	from	multiple	regressions	of	R2*	(from	the	ASPS	study)	and	T2*	(from	UK	Biobank)	








Imaging	 protocols	were	 designed	 by	 the	UK	 Biobank	 Imaging	Working	 Group	(www.ukbiobank.ac.uk/expert-
working-groups),	in	consultation	with	a	large	number	of	brain	imaging	experts	(listed	in	the	acknowledgments).	
MRI	 provides	 many	 imaging	 modalities	 offering	 complementary	 information.	 As	 part	 of	 this	 consultancy,	 a	
number	of	modalities	were	determined	to	be	infeasible	or	lower	priority	for	a	range	of	reasons.	Considerations	
included	time	constraints,	generalizability,	feasibility	of	automated	analysis,	and	existence	of		robust,	well-tested	
acquisition	 methods.	 The	 advisory	 network	 therefore	 decided	 not	 to	 include	 quantitative	 relaxometry,	 MR	
spectroscopy	or	angiography.	Arterial	spin	labeling	is	currently	being	piloted,	as	described	below.





primary	modality	categories	 (structural,	diffusion	and	 functional	MRI).	Order	of	 acquisition	was	 optimized	 in	




Further	 protocol	 details	 are	 available	 at:	 http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367 and further
description	 of	 post-processing	 pipelines	 and	 data	 outputs	 included	 in	 the	 first	 data	 release	 are	 available	 at:	



























scanned	 every	 36	minutes	without	 serious	 compromise	 to	 data	 quality	 compared	 to	 research	 protocols	 that	
might	 conventionally	 require	 up	 to	 an	 hour	 of	 scan	 time.	 Despite	 these	 tight	 time	 constraints,	 we	 aimed	 to	
include	as	many	MRI	modalities	as	possible,	 to	 take	advantage	of	 the	 full	richness	of	 information	 that	 can	be	
provided	by	MRI.	Here,	we	highlight	the	primary	considerations	that	required	a	different	approach	from	more	
conventional	imaging	studies.







Tight	 imaging	 FOVs	 (fields	 of	 view	 –	 the	 physical	 size	 of	 the	 imaged	 volume)	 are	 in	 general	 favorable	 to
reduce	scan	time;	however,	these	restrictions	exclude	subjects	with	larger	heads	or	brains.	For	UK	Biobank,	





It	 is	 critically	 important	 that	 all	 analyses	 are	 automated.	 This	 translates	 to	 an	 additional	 role	 for	 certain	
imaging	modalities	beyond	 their	 intrinsic	 information	 content.	 Thus,	 although	we	 considered	methods	 for	
reducing	scan	time for	T1-weighted	structural	scans	while	retaining	coverage	and	resolution	(e.g.,	elliptical	
sampling with	consequent	image	blurring),	this	was	deemed	an	unacceptable	risk	given	the	central	role	of	the	
T1	 to	 cross-subject	 and	 cross-modal	 alignment	 for	most	 processing	pipelines,	 including	 that	 implemented	
here	for	the	initial	data	release.
The	 EPI	 (echo-planar	 imaging)	 acquisitions	 for	 fMRI	 and	 dMRI	 result	 in	 significant	 image	 distortion	 that	
creates	local	misalignment	in	certain	brain	regions.	Correction	of	this	requires	measurement	of	the	magnetic	
field	 inhomogeneities	 that	 cause	 distortion.	 Two	 types	 of	 measurements	 are	 possible:	 a	 non-EPI	gradient-





To	provide	data	with	as	rich	and	broad	a	 range	of	applications	as	possible,	we	 include	 imaging	modalities	
that	are	not	yet	widely	used	in	clinical	practice,	such	as	fMRI	and	dMRI.	These	modalities	have	demonstrated	
mechanistic	 and	 biological	 insights,	 and	 will	 hopefully	 see	 greater	 clinical	 take-up	 in	 the	 future,	 in	 part	
because	 of	 projects	 such	 as	 UK	 Biobank.	 We	 took	 advantage	 of	 recent	 advances	 in	 acquisition,	 largely	











After early piloting, a clinical T2/PD-weighted acquisition was removed from the protocol. This decision
reflected the limited relevance to UK Biobank goals (given the inclusion of the higher-quality and more 
biologically informative T2 FLAIR) and the value in recovering this scan time (just over 1 minute).
One	 shortcoming	 of	 the	 current	 protocol	 is	 the	 lack	 of	 a	 direct	measure	 of	 neurovascular	 health.	 We	 are	














Informed	 consent	 is	 obtained	 from	 all	 UK	 Biobank	 participants;	 ethical	 procedures	 are	 controlled	 by	 a	
dedicated	Ethics	 and	Guidance	Council	 (http://www.ukbiobank.ac.uk/ethics)	 that	 has	 developed	with	 UK	
Biobank	 an	 Ethics	 and	 Governance	 Framework	 (given	 in	 full	 at	http://www.ukbiobank.ac.uk/wp-
content/uploads/2011/05/EGF20082.pdf),	 with	 IRB	 approval	 also	 obtained	 from	 the	 North	 West	Multi-
centre	Research	Ethics	Committee.
Subjects	 are	 excluded	 from	 scanning	 according	 to	 fairly	 standard	 MRI	 safety/quality	 criteria,	 such	 as	
exclusions	 for	metal	 implants,	 recent	 surgery,	 or	 health	 conditions	 directly	 problematic	 for	MRI	 scanning,	
such	as	problems	hearing,	breathing	or	extreme	claustrophobia.




The	 T1	 structural	 protocol	 is	 acquired	 at	 1mm	 isotropic	 resolution	 using	 a	 3D	 MPRAGE	 acquisition,	 with	














Images	are	 segmented	 into	 tissue	 types	 (gray	matter,	white	matter	 and	 cerebro-spinal	 fluid)
63
.	 	 Cortical	 gray	
matter	 volume	 is	 estimated,	 comparing	 the	 segmented	 gray	matter	 to	 an	atlas	 reference	 (where	 the	 external	
skull	 surface	 is	used	 to	 normalize	 for	 head	 size)
64






many	 of	 the	 IDPs	 are	 in	 fact	 generated	 from	within-subject	 analyses	 that	 do	 not	 depend	on	 exact	 voxelwise
spatial	alignment	to	standard	space	(or	between	subjects):	for	example,	283	of	the	715	structural	and	diffusion	
IDPs	do	not	rely	on	exact	spatial	alignment	and	are	carried	out	in	the	original	space	of	each	subjects’	data.




these	 hyperintensities	 is	 currently	 being	 developed	 and	 future	 data	 releases	 will	 include	 IDPs	 reflecting	 the	
lesion	“load”.
The	 swMRI	 scan	 uses	 a	 3D	 gradient	 echo	 acquisition	 at	 0.8x0.8x3mm	 resolution,	 acquiring	 two	 echo	 times	





processing.	Venograms are generated through non-linear filtering of the magnitude and phase images12, 
which produces enhanced conspicuity of medium and large veins. Automated segmentation of microbleeds
and venograms would provide significant value, but to our knowledge robust tools for this are not yet 
available; future pipeline versions can hope to include such analyses. Future work will also consider whether 
this data will support quantitative susceptibility mapping, which would provide further information on tissue 
constituents as discussed in the main text. 
Diffusion	Imaging
Diffusion	 data	 is	 acquired	 with	 two	 b-values	 (b=1000	 and	 2000	 s/mm
2
)	 at	 2mm	 spatial	 resolution,	 with	
multiband	 acceleration	 factor	 of	 3	 (three	 slices	 are	 acquired	 simultaneously	 instead	 of	 just	 one).	 For	 each
diffusion-weighted	 shell,	 50	 distinct	 diffusion-encoding	 directions	 were	 acquired	 (covering	 100	 distinct	
directions	over	the	two	b-values).	The	diffusion	preparation	is	a	standard	(“monopolar”)	Stejskal-Tanner	pulse	











anisotropy,	 tensor	 mode	 and	 mean	 diffusivity.	 The	 NODDI
16
	 model	 is	 fit	 using	 the	 AMICO	 (Accelerated 
Microstructure Imaging via Convex Optimization)	tool
52
,	with	outputs	including	intra-cellular	volume	fraction	
(which	 is	 often	 interpreted	 to	 reflect	 neurite	 density)	 and	 orientation	 dispersion	 (a	measure	 of	 within-voxel	
disorganization).	 For	 tractography,	 a	 parametric	 approach	 is	 first	 used	 to	 estimate	 fibre	 orientations.	 The	















and	 names).	 The	 second	 approach	 utilizes	 subject-specific	 probabilistic	 diffusion	 tractography	 run	 using	
standard-space	 protocols	 to	 identify identify	 27	 tracts
18
;	 in	 this	 case,	 the	 output	 IDPs	 are	 weighted	 by	 the	
tractography	 output	 to	 emphasize	 values	 in	 regions	 that	 can	 most	 confidently	 be	 attributed	 to	 the	 tract	 of	





with	multiband	 acceleration	 factor	 of	 8.	 A	 “single-band”	 reference	 image	 (without	 the	 multiband	 excitation,	
exciting	each	 slice	 independently)	 is	 acquired	 that	 has	 higher	 tissue-type	 image	 contrast;	 this	 is	 used	 as	 the	













the	 face	 (or	 shape)	 at	 the	 top	 of	 the	 screen.	 The	 faces	 have	 either	 angry	 or fearful	 expressions.	 The	 ePrime




these,	 the	 three	 activation	 contrasts	 of	 most	 interest	 (shapes,	 faces	 and	 faces>shapes)	 are	 used	 to	 generate	
output	measures,	including	two	IDPs	for	the	faces-shapes	task	(one	including	all	voxels	above	a	group-level	fixed-
effects	 Z>120,	 and	 one	 including	 only	 the	 amygdala	 regions	 above	 threshold).	 IDPs	 corresponding	 to	 both	
percent	signal	change	and	statistical	significance	(Z	statistics)	are	generated.
During	resting-state	scans,	subjects	are	instructed	to	keep	their	eyes	fixated	on	a	crosshair,	relax	and	“think	of	





for	each	subject	 is	 further	“cleaned”	using	an	 ICA-based	algorithm	 for	automatically	 identifying	and	removing	
structured	 artefacts
76




components.	 Where	 a	 small	 (<30)	 number	 of	 components	 is	 estimated
78
,	 it	 is	 common	 to	 consider	 each	
component	as	a	separate	“network”	in	its	own	right; each	component	will	often	include	several	non-contiguous	














ICA	 components	 considered	 to	 be	 artefactual	 (i.e.,	 relating	 either	 to	 scanning	 artefacts,	 or	 to	 non-neuronal	
biophysical	processes	 such	 as	 cardiac	 fluctuations	 and	head	motion),	 this	 results	 in	 21	 and	 (respectively)	55	
nodes	left	for	forming	the	IDPs	such	as	network	matrices	(functional	connectivities	between	pairs	of	nodes).
Quality	control
To	 date,	 raw	 data	 and	 pipeline	 outputs	 have	 been	 manually	 checked	 for	 gross	 problems	 of	 quality	 and	
robustness,	 with	 problematic	 data	 tagged	 and	 removed	 from	 pipeline	 outputs;	 see	 main	 text	 for	 results	 on	
proportions	of	usable	data	 in	 the	different	modalities.	However	several	quality-related	 IDPs	are	automatically	








As	 described	 below,	 univariate	 statistics	 were	 primarily	 carried	 out	 using	 Pearson	 correlation	 (though	 see	
details	 below	 regarding	 Gaussian-distribution	 normalization	 and	 linear	 removal	 of	 confound	 effects)	 and	
multivariate	statistics	were	carried	out	using	a	combination	of	canonical	correlation	analysis	and	independent	
component	analysis	(with	permutation	testing	used	to	identify	the	significant	number	of	components	estimable).	
As	discussed	 in	 the	main	 text,	 the	primary	rationale	 for	 the	size	of	 the	study	 is	not	 to	 boost	 statistical	 power	
across	100,000	subjects,	but	rather	to	provide	prospective	imaging	data	suitable	for	discovering	early	markers	
and	 risk	 factors	 for	 as	 broad	 a	 set	 of	 diseases	 as	 possible,	 both	 rare	 and	 highly	 prevalent.	 Hence	 while	








extracted	 from	the	UK	Biobank	database	 (these	 other	 variables	 are	mostly	 not	 derived	 from	 imaging,	 though	
some	do	come	from	the	non-brain	imaging	modalities);	for	the	list	of	general	classes	of	these	variables,	see	Fig.
6a,	and	for	many	examples	of	individual	variables,	see	the	lists	associated	with	the	CCA-ICA	modes	presented	in
Fig.	 7	 and	 Supplementary	 Figs.	 The	 initial	 set	 of	 variables	 extracted	 from	 the	 UK	 Biobank	 database	 was	
automatically	 reduced	 to	 those	 (1100	 variables)	 containing	 sufficient	 numbers	 of	 valid	 (non-missing)	 data	
entries,	 using	 very	 similar	 selection	 rules	 to	 those	 applied	 in	 the	 recent	 CCA-based	 analysis	 of	 Human	
Connectome	Project	data
34
. Some	variables	are	defined	(in	 the	UK	Biobank	database)	 such	 that	 the numerical	
encoding	is	the	inverse	of	what	one	might	naturally	assume	-	for	example	in	the	variable	"Qualifications",	higher	
numbers	refer	to lower	levels	of	educational	qualifications.	 In	such	cases	we	have inverted	the	sign	of	the	ICA	






Eight	 confound	variables	 are	 generated:	 age,	 age
2










with	 aging	 (r=0.15	 in	 this	 data);	 hence,	 if	 not	 adjusted	 for,	 uninteresting	 associations	 would	 likely	 arise.	
However,	some	measures	may	have	both	biologically	interesting	associations	with	IDPs,	and	also	act	as	imaging	














































estimating	 first	 a	 pseudo-covariance	 matrix	 ignoring	 missing	 data,	 projecting	 this	 onto	 the	 nearest	 valid	
(positive	definite)	covariance	matrix,	and	then	carry	out	an	eigenvalue	decomposition.	The	 two	resulting	 (IDP	
and	non-IDP)	matrices	of	size	5034×200	are	then	fed	into	standard	CCA	(“canoncorr”	in	Matlab),	resulting	in	200	
CCA	 modes	 being	 estimated.	 The	 CCA	 aims	 to	 identify	 symmetric	 linear	 relations	 between	 the	 two	 sets	 of	
variables.	Each	significant	CCA	mode	 identifies	a	 linear	 combination	 of	 IDPs	 and	 a	 linear	combination	 of	non-






the	CCA	modes	estimated.	Nine	modes	are	 found	 to	be	significant	 (Pcorrected<0.002,	with	all	 later	modes	having	





order	 to	 take	 full	 advantage	 of	 the	 numbers	 of	 variables	 originally	 prepared,	 we	 first	multiply	 the	 nine	 CCA	














As	described	 above,	 all	 source	 data	 (including	 raw	 and	processed	brain	 imaging	 data,	 derived	 IDPs,	 and	non-
imaging	 measures)	 is	 available	 from	 UK	 Biobank	 via	 their	 standard	 data	 access	 procedure	 (see	
www.ukbiobank.ac.uk/register-apply).	
The	 image	 processing	 pipeline	 will	 be	 made	 publicly	 available	 in	 early	 2017	 from	
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ICA100 network connectivity - mode 8
ICA100 network connectivity - mode 9
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															ASPS														UK	Biobank	
									R2*-BMI	regression			T2*-BMI	regression	
													beta	-log10PFDR						beta	-log10Puncorr	
Thalamus						0.029		0								L	-0.0239			0.7	
																														R	-0.0187			0.5	
Caudate							0.046		0								L	-0.0789			4.5	
																														R	-0.0746			4.1	
Putamen							0.044		0								L	-0.0570			2.6	
																														R	-0.0649			3.2	
Pallidum					-0.002		0								L	-0.0661			3.2	
																														R	-0.0772			4.1	
Hippocampus			0.135		>4.0					L	-0.1390		14.2	
																														R	-0.1343		13.7	
																											MEAN	-0.1490		17.0	
Amygdala						0.232		2.0						L	-0.0786			4.6	
																														R	-0.0478			2.0	
																											MEAN	-0.0701			3.9	
Accumbens				-0.048		0								L	-0.0117			0.2	
																														R	-0.0040			0.1
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